REG - Morgan Stanley Cap - Rule 38.5 - ABBVIE INC.

Morgan StanleyAnnouncement

17/04/2020 11:10

RNS Number : 0280K
  
Morgan Stanley Capital Services LLC
  
17 April 2020
  
 

 
 FORM 38.5 
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER  RULES, 2007 (AS AMENDED)
 
DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS
 
1.             KEY INFORMATION



 Name of exempt market-maker


   Morgan Stanley Capital Services LLC




 Company dealt in


   ABBVIE INC.




 Class of relevant security to which the dealings being disclosed relate (Note 1)


  US$0.01 COMMON STOCK




 Date of dealing


   16 APRIL 2020



 
 
2.             DEALINGS (Note 2)
 
(a)           Purchases and sales



 Total number of relevant secuities accquired


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  18,317


 83.5650 USD


 81.6700 USD



 



 Total number of relevant secuities disposed


 Highest price paid (Note 3)


 Lowest price paid (Note 3)




  17,957


 83.5000 USD


 81.8400 USD



 
 
(b)           Derivatives transactions (other than options transactions)
 



 Product name, e.g. CFD


 Nature of transaction 
                (Note 4)


 Number of relevant securities 
                (Note 5)


 Price per unit




 CFD


 LONG


 230


 81.8600 USD




 CFD


 LONG


 463


 82.4413 USD




 CFD


 LONG


 1,053


 82.5682 USD




 CFD


 LONG


 95


 82.7300 USD




 CFD


 LONG


 56


 83.3680 USD




 CFD


 LONG


 17


 83.3682 USD




 CFD


 LONG


 33


 83.4900 USD




 CFD


 LONG


 16


 83.5000 USD




 CFD


 SHORT


 577


 81.8600 USD




 CFD


 SHORT


 4


 81.8600 USD




 CFD


 SHORT


 581


 81.9661 USD




 CFD


 SHORT


 990


 81.9661 USD




 CFD


 SHORT


 79


 81.9661 USD




 CFD


 SHORT


 1,000


 82.1250 USD




 CFD


 SHORT


 4,067


 82.2080 USD




 CFD


 SHORT


 1,322


 82.2742 USD




 CFD


 SHORT


 78


 82.2742 USD




 CFD


 SHORT


 5,100


 82.4357 USD




 CFD


 SHORT


 37


 82.7600 USD



 
 
(c)            Options transactions in respect of existing relevant securities
 
i)           Writing, selling, purchasing or varying
 



 Product name, eg call option


 Writing, selling, purchasing, varying etc


 Number of securities to which the option relates (Note 5)


 Exercise Price


 Type, e.g American, European etc 


 Expiry Date 


 Option money paid/received per unit (Note 3)




 N/A


 N/A


 N/A


 N/A


 N/A


 N/A


 N/A 



 
(ii) Exercising
 



 Product name, eg call option


 Number of securities


 Exercise price per unit (Note 3)




 N/A


 N/A


 N/A  



 
 
3. OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 



Full Details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 




 
 
 
 
 



 
 



 Date of disclosure


 17 APRIL 2020




 Contact Name


Craig Horsley




 Telephone Number


+44(141) 245 7736 




 Name of offeree/offeror with which connected


ABBVIE INC. 




Nature of connection (Note 6)


Advisory 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
ISEUBRKRRVUSARR